Jynarque 45MG/15MG
Ended Awarded
- Contract number
- 36C26124N0635
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Las Vegas, NV 89086, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $12,580.72 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. on May 6, 2024, for the supply of Jynarque 45mg/15mg tablets. This delivery order is issued under the company's larger Blanket Purchase Agreement (BPA) valued at $83.3 million for Jynarque, which was established under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with an ultimate completion date of March 26, 2026. The place of performance is identified as North Las Vegas, Nevada. No set-aside designation was utilized for this award, reflecting Otsuka America Pharmaceutical Inc.'s status as a large, established pharmaceutical manufacturer.
Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring specialized treatment options for veteran populations. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, maintains significant pharmaceutical supply contracts with the VA across multiple integrated service networks and operates a broader $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. This delivery order supports the Veterans Health Administration's mission to provide critical pharmaceutical treatments to veterans nationwide through streamlined procurement mechanisms.
Quick answers
Who was awarded contract 36C26124N0635?
36C26124N0635 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 6, 2024.
How much is contract 36C26124N0635 worth?
The government has obligated $12,581 on 36C26124N0635.
Is contract 36C26124N0635 an order under another contract?
Yes. 36C26124N0635 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0635 competed?
The extent of competition for 36C26124N0635 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award